We investigated the possibility that the inflammatory reaction in primary acquired cold urticaria might be associated with the release of platelet-activating factor. Six patients with the disease and five normal controls were subjected to cold-water challenges during which blood samples were obtained for measurement of the release of possible mediators: i.e., histamine, neutrophilic chemotactic activity, and platelet-activating factor-like lipid (PAF-LL). Four of the patients had pronounced experimentally induced cold urticaria with angioedema and release of mediators. Levels of the three mediators were not elevated in five normal controls or in two patients in whom cold challenges induced only mild urticaria and angioedema. The effective suppression of cold-induced urticaria in three patients treated with doxepin correlated with inhibition of PAF-LL release but not inhibition of histamine or neutrophilic chemotactic activity release. These data suggest a positive correlation between PAF-LL release and cold urticaria, although the exact relation between PAF-LL and cutaneous lesions of primary acquired cold urticaria has not yet been established.
This article has been cited by other articles:
Bonin, F., Ryan, S. D., Migahed, L., Mo, F., Lallier, J., Franks, D. J., Arai, H., Bennett, S. A. L.
(2004). Anti-apoptotic Actions of the Platelet-activating Factor Acetylhydrolase I {alpha}2 Catalytic Subunit. J. Biol. Chem.
279: 52425-52436
[Abstract][Full Text]
Marques, S. A., Dy, L. C., Southall, M. D., Yi, Q., Smietana, E., Kapur, R., Marques, M., Travers, J. B., Spandau, D. F.
(2002). The Platelet-Activating Factor Receptor Activates the Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase and Induces Proliferation of Epidermal Cells through an Epidermal Growth Factor-Receptor-Dependent Pathway. J. Pharmacol. Exp. Ther.
300: 1026-1035
[Abstract][Full Text]
Pei, Y., Barber, L. A., Murphy, R. C., Johnson, C. A., Kelley, S. W., Dy, L. C., Fertel, R. H., Nguyen, T. M., Williams, D. A., Travers, J. B.
(1998). Activation of the Epidermal Platelet-Activating Factor Receptor Results in Cytokine and Cyclooxygenase-2 Biosynthesis. J. Immunol.
161: 1954-1961
[Abstract][Full Text]
Barber, L. A., Spandau, D. F., Rathman, S. C., Murphy, R. C., Johnson, C. A., Kelley, S. W., Hurwitz, S. A., Travers, J. B.
(1998). Expression of the Platelet-activating Factor Receptor Results in Enhanced Ultraviolet B Radiation-induced Apoptosis in a Human Epidermal Cell Line. J. Biol. Chem.
273: 18891-18897
[Abstract][Full Text]
Haas, N., Toppe, E., Henz, B. M.
(1998). Microscopic Morphology of Different Types of Urticaria. Arch Dermatol
134: 41-46
[Abstract][Full Text]
Drake, L. A., Millikan, L. E., Doxepin Study Group,
(1995). The Antipruritic Effect of 5% Doxepin Cream in Patients With Eczematous Dermatitis. Arch Dermatol
131: 1403-1408
[Abstract]
HUSTON, D. P., BRESSLER, R. B., KALINER, M., SOWELL, L. K., BAYLOR, M. W.
(1986). Prevention of Mast-Cell Degranulation by Ketotifen in Patients with Physical Urticarias. ANN INTERN MED
104: 507-510
[Abstract]
Previous
